# Contango Silver & Gold Inc.: overview CTGO · NYSE · CIK 1502377 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ctgo.md) · [Financials](/companies/ctgo/financials.md) · [Filings](/companies/ctgo/filings.md) · [Insiders](/companies/ctgo/insiders.md) Latest reported revenue: [$750.0k](/filings/0001502377-15-000008.md) for Q3 FY2015, three months to 2015-03-31, from the 10-Q filed May 15, 2015 (XBRL us-gaap:SalesRevenueNet, accession 0001502377-15-000008). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.81)](/filings/0001193125-25-280434.md) | not reported | [(1.88)](/filings/0001193125-26-222855.md) | [1.24](/filings/0001193125-26-349539.md) | [(0.44)](/filings/0001193125-25-280434.md) | not reported | [(0.83)](/filings/0001193125-26-222855.md) | [0.14](/filings/0001193125-26-349539.md) | | Free cash flow | $m | [17.5 d](/filings/0001193125-25-280434.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(3.49)](/filings/0000950170-24-031469.md) | [(5.61)](/filings/0000950170-25-039841.md) | [(7.14)](/filings/0000950170-25-039841.md) | [(3.49)](/filings/0001193125-26-107141.md) | [(2.80)](/filings/0001193125-26-107141.md) | | Free cash flow | $m | [(14.0)](/filings/0000950170-24-031469.md) | [(14.7)](/filings/0000950170-25-039841.md) | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ctgo/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $36.9m | 2,337,677 | | Added +2,061,916 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $34.2m | 2,164,928 | | Added +839,137 | | [Alyeska Investment Group, L.P.](/funds/1453072.md) | 2026-06-30 | $33.6m | 2,127,579 | | Added +750,000 | | [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $20.3m | 1,287,609 | | Added +24,836 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $19.2m | 1,217,000 | | Added +529,014 | | [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $12.9m | 819,087 | | Added +364,062 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $10.6m | 668,160 | | Added +85,478 | | [BARINGS LLC](/funds/9015.md) | 2026-06-30 | $7.5m | 476,190 | | Unchanged | | [Ninepoint Partners LP](/funds/1715635.md) | 2026-06-30 | $5.7m | 361,899 | | Not compared | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $4.2m | 266,752 | | Reduced −36,237 | ## Recent filings [All 689 filings](/companies/ctgo/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-06 | 09:28 ET | [8-K](/filings/0001193125-26-415031.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-415031 | | 2026-09-22 | 08:00 ET | [8-K](/filings/0001104659-26-109483.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-109483 | | 2026-09-15 | 16:30 ET | [8-K](/filings/0001193125-26-391986.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-391986 | | 2026-09-09 | 08:00 ET | [8-K](/filings/0001193125-26-385909.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-385909 | | 2026-09-02 | 09:00 ET | [8-K](/filings/0001193125-26-379446.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-379446 | | 2026-08-19 | 17:00 ET | [8-K](/filings/0001193125-26-357092.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-357092 | | 2026-08-14 | 16:30 ET | [8-K](/filings/0001193125-26-352418.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-352418 | | 2026-08-13 | 17:00 ET | [10-Q](/filings/0001193125-26-349539.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349539 | | 2026-07-17 | 16:30 ET | [8-K](/filings/0001193125-26-307893.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-307893 | | 2026-07-08 | 16:30 ET | [8-K](/filings/0001193125-26-298578.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-298578 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-107141.md), filed Mar 16, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1502377 - Tickers: CTGO - Exchange: NYSE - SIC code: 1040 Gold and Silver Ores - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 28, 2026, 09:04 ET. No prices; not investment advice.